Drug Type Small molecule drug  | 
Synonyms-  | 
Target  | 
Action degraders  | 
Mechanism IRAK4 degraders(Interleukin-1 receptor-associated kinase 4 degraders)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhaseDiscovery  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 13 Feb 2025 | |
| Cardiovascular Diseases | Discovery | - | 13 Feb 2025 | |
| Endometriosis | Discovery | - | 13 Feb 2025 | |
| Endometriosis | Discovery | - | 13 Feb 2025 | |
| Hepatitis | Discovery | - | 13 Feb 2025 | |
| Hepatitis | Discovery | - | 13 Feb 2025 | |
| Immune System Diseases | Discovery | - | 13 Feb 2025 | |
| Immune System Diseases | Discovery | - | 13 Feb 2025 | |
| Infectious Diseases | Discovery | - | 13 Feb 2025 | |
| Infectious Diseases | Discovery | - | 13 Feb 2025 | 





